Navigation Links
Haemacure Update on Proposed Collaboration and Bridge Financing
Date:5/22/2009

of the statements contained in this news release are forward-looking statements. Such statements, based as they are on the current expectations of management, inherently involve numerous risks and uncertainties, known and unknown. Some examples of known risks are: the impact of general economic conditions, general conditions in the biotech industry, changes in the regulatory environment in the jurisdictions in which Haemacure does business, stock market volatility, fluctuations in costs, and changes to the competitive environment due to consolidation or otherwise. Consequently, actual future results may differ materially from the anticipated results expressed in the forward-looking statements. Haemacure disclaims any intention or obligation to update these statements.


'/>"/>
SOURCE Haemacure Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. Haemacure Signs Term Sheet for Proposed Collaboration and Bridge Financing
2. Haemacure Reports First Quarter 2009 Results and Hires Advisor for the Sale or Merger of the Company
3. Haemacure Restructures - Seeks Financing or Sale of the Company
4. Haemacure to Present at the 11th Annual BIO CEO & Investor Conference
5. Haemacure Announces Fiscal 2008 Results
6. Haemacures Human Fibrin Sealant Demonstrates Effectiveness in Skin Graft Fixation Proof-of-Concept Study for Burn Injury
7. Haemacure Confirms Operation Qualification of Production Equipment and Pursues Milestone Payment from CSL
8. Haemacure to Present at the Rodman & Renshaw Annual Global Investor Conference
9. Haemacure Appoints Thomas J. Lynch, J.D., Ph.D. to Board of Directors
10. Adhesion Prevention New Major Market Opportunity, Haemacure Confirms Effectiveness of its Fibrin Sealant in Second Preclinical Study in Adhesion Prevention in a Bleeding Model
11. Haemacure Raises $7.8 Million and is Fully Funded Beyond First-Patient-In-Clinic

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/7/2009)... , HOUSTON, Nov. 7 ...esented Lisa James, Director of Health at the Fami... Distinguished Service today at its semi-annual po...ed Service is the highest honor the AMA House of D...: http://www.newscom.com/cgi-bin/prnh/20081209/...
(Date:11/7/2009)... , Brown: "Faithful Catholics have a respon...re, not negotiate the status quo." ,, WASHING... Life League president Judie Brown released the fo... Rigali will support Speaker Nancy Pelosi,s Afford...ided an amendment preserving the status quo for ab...
(Date:11/7/2009)...Parents should not assume that all youth will rebe...hDay News) -- Teens are more likely to behave badl...y has found. , "Parents who believe they are simpl...elf-fulfilling prophecy," Christy Buchanan, a psyc...author of the study, said in a university news rel...
(Date:11/7/2009)..., A new foot spray from G...with the power of hot peppers and caffeine. Therma...g natural formula that also contains Black Walnut,... Schenectady, NY (PRWEB) N...ons fights pain and increases circulation with the...
(Date:11/6/2009)..., WHITE PLAINS, N.Y., Nov. 6 The Leukemia &am...ing in Gap Inc.,s Give & Get program, which in...er, garnered more than $1 million to support LLS,s...on and support services. ,, During the campaign, t...ill issue downloadable 30% discount coupons pa...
Breaking Medicine News(10 mins):Health News:AMA Honors Family Violence Prevention Expert 2Health News:Statement Regarding Cardinal Rigali's Memo Protecting the 'Status Quo' On Life 2Health News:Bad-Behaving Teens May Be Living Up to Expectations 2Health News:Hot Peppers and Caffeine Relieve Painful Feet, Toe Fungus and Foot Odor 2Health News:Get a Jump on Your Holiday Shopping and Give Two Gifts This Season: One to Your Loved Ones and One to People Battling Blood Cancer 2
...y the most common neurological disorder and one of...ve million people die of stroke each year and more...the question of the day is about the recovery - wh...n Maryland devised a method which allows doctors t...
...pe I, is due to autoimmune destruction of the panc... this the body no longer produces insulin and and ...duals with this type I Diabetes develop are at a h... Los Angeles did a study involving 57 diabetics ag...
...one of the common neurological problems affecting ...any underlying disease. If you happen to be one of...aine, then there is a reason to celebrate. Yes, th...gress of Neurology told that tizanidine, can cut t...
...umber of advertisements by the drug companies has ... prescription drug ads from television, news paper...w Jersey delegate Dr. Angelo agro said that such a...ded that ads have tuned into a competition "to see...
...n the density of the bone is lost and becomes brit...after they attain their menopause. This happens as...s responsible for maintaining the bone density. ...nt bone loss after menopause as effectively as est...
...is on the rise. But the alarm bells are soaring ag...female smokers with breast cancer face an increase...other organs than do nonsmokers "There is a re...ifornia at Davis. Dr. Murin says the research m...
Other Medicine News:
(Date:11/6/2009)...IEGO, Nov. 6 Ardea Biosc...pany focused on the development of small-molecule ... human immunodeficiency virus (HIV), today reporte... the third quarter and nine months ended September...cgi-bin/prnh/20091104/ARDEALOGO ) ,, "Since our...
(Date:11/6/2009)...ON, Nov. 6 Cyberonics, I...any will report financial results for the second q...nding April 30, 2010 on Wednesday, November 18, 20...ference call to discuss those results on Thursday,...Year 2010 Second Quarter Results Conference Call I...
(Date:11/6/2009)...IT, Nov. 6 Caraco Pharma... launched ketorolac tromethamine ophthalmic soluti...od and Drug Administration (FDA) for Sun Pharma,s ...c Acular® opthalmic solution on the first day...orolac is therapeutically equivalent to Acular...
Breaking Medicine Technology:Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 2Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 3Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 4Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 5Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 6Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 7Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 8Cyberonics Announces Conference Call to Discuss Fiscal Year 2010 Second Quarter Financial Results 2Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution 2New Isolation Valves With Inert Body And Diaphragm Materials Added To Gems Family 60353 1New Isolation Valves With Inert Body And Diaphragm Materials Added To Gems Family 60353 2New Isolation Valves With Inert Body And Diaphragm Materials Added To Gems Family 60353 3President Selected to Open Sanford Brown Institute Grand Rapids 60350 1President Selected to Open Sanford Brown Institute Grand Rapids 60350 2House Healthcare Bill 3A Government Run Plan Other Key Provisions Undermine Goals of Access and Affordability 60346 1House Healthcare Bill 3A Government Run Plan Other Key Provisions Undermine Goals of Access and Affordability 60346 2House Healthcare Bill 3A Government Run Plan Other Key Provisions Undermine Goals of Access and Affordability 60346 3
.... (NHSi) has won a two-year award of $1.9 million ...of the National Institutes of Health (NIH) to deve...The project aims to develop the Hemanext Anaerobic...lood for transfusion therapy and extends the shelf...onstrated that this new technology can deliver hig...
...ty for Acute Pain Patients , , RARITAN, N.J., May...people who have surgery experience gastrointestina...se of opioid pain medicines during and after surge... side effects. Nausea and vomiting are uncomfortab...ent,s recovery. , , According to a new Phase 3 cl...
Other Medicine Technology:Bethesda-Based NHSi Wins $2M Grant for Blood Technology 2Bethesda-Based NHSi Wins $2M Grant for Blood Technology 3New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 2New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 3New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 4New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 5New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 6New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 7New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 8
SureCut M3500 Fuses, Spare
Feather Disposable Blades, Pack of 50
SureCut M3500 Abrasive, Coarse, Knife Sharpening
SureCut M3500 Standard Knife w/ Box, C Profile
Medicine Products: